|
Hasan Ahmad, M.D., associate professor of medicine, received a $375,096 grant from Novartis Pharmaceuticals for "A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)/Protocol Number CKJX839D12302.”
Fawaz Al-Mufti, M.D., associate professor of neurology, neurosurgery, and of radiology, received a $54,845 grant from Cerenovus for "Retrospective Real-World Evidence Study Real World Evidence Study to Characterize the Performance and Safety of the CEREGLIDE™ 71 Intermediate Catheter for Aspiration Neurothrombectomy."
Malik Bisserier, Ph.D., assistant professor of cell biology and anatomy and of physiology, received a $40,000 grant from the American Thoracic Society for "LSD1 as a Target for Restoring Endothelial Cell Function for PAH.”
Mitchell Cairo, M.D., professor of pediatrics, medicine, cell biology and anatomy, and of pathology, microbiology, and immunology, received a $200,000 grant from the Pediatric Cancer Foundation for "Reducing the Burden of Oncologic Chemotherapy and Radiation Exposure Utilizing Targeted Immunotherapy in Children, Adolescents and Young Adults with Lymphoma"; a $56,959 grant from Kadmon Corporation for "KD025-218, A Phase 2, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Participants with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy"; and a $5,000 grant from Alex’s Lemonade Stand Foundation for a student researcher for “Investigating the Effects of Targeted Chimeric Antigen Receptor Natural Killer Cells Armored with Tumor-Attracting Chemokine Receptors Combined With a Novel Immunomodulator in the Treatment of Osteosarcoma."
Victor Garcia, Ph.D., assistant professor of pharmacology, received a $85,000 grant from Orion Biotechnology Canada Limited for "Orion Biotechnology: Investigating GPR75 blockade in diet-induced obesity and beyond."
Christine Hom, M.D., clinical assistant professor of pediatrics, received a $399,211 grant from AbbVie, Inc. for “Systemic Juvenile Idiopathic Arthritis: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Active Systemic Juvenile Idiopathic Arthritis.”
Mark Hurwitz, M.D., professor and chair, Department of Radiation Medicine, received a $258,714 grant from Merck Sharp & Dohme LLC for “A Phase 3, Randomized, Double-blind, Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) versus CRT Alone in Participants with Muscle-invasive Bladder Cancer (MIBC) (KEYNOTE-992).”
Diwakar Jain, M.D., professor of medicine, received a $273,442 grant from Janssen Research and Development, LLC for “A Phase 3, Randomized, Double-blind, Placebo-controlled, Event-driven Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, After a Recent Acute Coronary Syndrome LIBREXIA-ACS.”
Igor Laskowski, M.D., Ph.D., associate professor of surgery, received a $63,525 grant from Altrazeal Life Science, Inc. for “Randomized Clinical Trial to Compare Transforming Powder and Standard of Care Dressing Therapies to Heal Diabetic Foot Ulcers.”
Suguru Ohira, M.D., associate professor of surgery, received a $233,940 grant from W.L. Gore & Associates, Inc. for “Evaluation of the GORE Ascending Stent Graft (ASG device) in the Treatment of Lesions of the Ascending Aorta (Protocol No. ASG 22-02).”
Chioma Okeoma, Ph.D., professor of pathology, microbiology, and immunology, received a $97,364 grant from the National Institutes of Health for "ProteinSimple Jess System for Protein Analysis at NYMC."
Helen Perakis, M.D., assistant professor of surgery, received a $152,250 grant from Altrazeal Life Science, Inc. for “Randomized, Controlled, Open-Label, Parallel Group, Multi-Center, Prospective Phase 4 Study Comparing the Efficacy of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries.”
Marcello Rota, Ph.D., associate professor of physiology, received a $300,000 grant from the American Heart Association for "Sympathovagal Balance Conditions of Manifestation of Cardiometabolic Syndrome.”
Gunjan Shukla, M.D., assistant professor of medicine, received a $301,337 grant from Boston Scientific Corporation "A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation.”
Katrina Stidham, M.D., associate professor of otolaryngology, and assistant professor of neurosurgery, received a $6,825 grant from Advanced Bionics LLC for “Retrospective Study of Advanced Bionics Recipient Outcomes with Single-Sided Deafness and Asymmetric Hearing Loss” Dr. Stidham in collaboration with Christine Colasacco, SOM Class of 2025, received a $10,720 grant from MED-EL Corporation for “Utilization of intra-operative IFT matrix to rule out electrode tip fold-over peri-operatively.”
Christopher Whitehurst, Ph.D., assistant professor of pathology, microbiology, and immunology and of biochemistry and molecular biology, received a $222,750 grant from the National Institutes of Health for "Targeting EBV's Deubiquitinating Activity for Therapy."
Dazhong Xu, Ph.D., associate professor of pathology, microbiology, and immunology, and Marietta Lee, Ph.D., professor emeritus of biochemistry and molecular biology, received a $206,198 grant from the National Institutes of Health for "The role of DNA Polymerase Delta 4 in Lung Carcinogenesis Induced by Genotoxic Carcinogens."
| 
